cardiology careers collections past issues search home
     

J Am Coll Cardiol, 1999; 33:1829-1832
© 1999 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kennedy, J. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kennedy, J. W.

Thrombolytic therapy in acute myocardial infarction

J. Ward Kennedy, MD, MACCa

a Seattle VA Medical Center, Seattle, Washington, USA



View larger version (11K):

[in a new window]
 
Figure 1 Survival analysis of all 533 patients allocated to intracoronary streptokinase or conventional therapy (control). Numbers denote patients at risk at the various intervals after treatment with streptokinase (top) or conventional therapy (below). Follow-up data were complete at three years. From Simoons et al. (7).

 




 
  cardiology careers collections past issues search home